Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide Structure
N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide structure
CAS No.
4201-62-1
Chemical Name:
N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide
Synonyms
C16LacCer;C16:0LacCer;LacCer(d18:1/16:0);C16 Lactosylceramide;Ceramide β-D-lactosides;N-Hexadecanoyl-lactosylceramide;C16 Lactosylceramide (d18:1/16:0));C16 Lactosyl(ss) Ceramide(d18:1/16:0);C16 Lactosyl(β) Ceramide (d18:1/16:0);LacCer d18:1/16:0 (Galb1,4GlcbCeramide)
CBNumber:
CB82190224
Molecular Formula:
C46H87NO13
Molecular Weight:
862.18
MDL Number:
MFCD08703001
MOL File:
4201-62-1.mol
MSDS File:
SDS
Last updated:2026-01-13 11:25:38
Request For Quotation

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide Properties

Boiling point 989.4±65.0 °C(Predicted)
Density 1.15±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Chloroform:Methanol:Water (2:1:0.1): Soluble
form A solid
pka 12.79±0.70(Predicted)
InChIKey HLIJNIKSBCIDGO-QKLMXXKVSA-N
SMILES [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O[C@H](O2)[C@H](O)[C@@H](O)[C@H]([C@H]2CO)O
UNSPSC Code 12352211
NACRES NA.25

SAFETY

Risk and Safety Statements

Storage Class 11 - Combustible Solids

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide price More Price(9)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 24352 C16 Lactosylceramide (d18:1/16:0) ≥98% 4201-62-1 500μg $186 2026-04-30 Buy
Cayman Chemical 24352 C16 Lactosylceramide (d18:1/16:0) ≥98% 4201-62-1 1mg $316 2026-04-30 Buy
Cayman Chemical 24352 C16 Lactosylceramide (d18:1/16:0) ≥98% 4201-62-1 5mg $739 2026-04-30 Buy
ChemScene CS-0865287 LacCer (d18:1/16:0) ≥98% 4201-62-1 1mg $652 2026-06-04 Buy
ChemScene CS-0865287 LacCer (d18:1/16:0) ≥98% 4201-62-1 5mg $1305 2026-06-04 Buy
Product number Packaging Price Buy
24352 500μg $186 Buy
24352 1mg $316 Buy
24352 5mg $739 Buy
CS-0865287 1mg $652 Buy
CS-0865287 5mg $1305 Buy

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide Chemical Properties, Uses, Production

Description

C16 Lactosylceramide is an endogenous bioactive sphingolipid.1 It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle.2 C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder.3

Uses

LacCer (d18:1/16:0) (C16 Lactosylceramide (d18:1/16:0)) is an endogenous bioactive sphingolipid that can form membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs). The levels of LacCer (d18:1/16:0) are elevated in the plasma of insulin-resistant cattle. In a mouse model of Niemann-Pick type C1 disease (a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder), the expression of LacCer (d18:1/16:0) is also upregulated. LacCer (d18:1/16:0) can be used in research on metabolic diseases and neurodegenerative diseases[1][2][3].

Definition

ChEBI: Beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-hexadecanoylsphingosine is a beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine in which the acyl group specified is hexadecanoyl. It has a role as a mouse metabolite. It is functionally related to a hexadecanoic acid.

References

1. Iwabuchi, K., Nakayama, H., Oizumi, A., et al. Role of ceramide from glycosphingolipids and its metabolites in immunological and inflammatory responses in humans Mediators Inflamm. 2015,120748(2015).
2. Rico, J.E., Bandaru, V.V., Dorskind, J.M., et al. Plasma ceramides are elevated in overweight Holstein dairy cows experiencing greater lipolysis and insulin resistance during the transition from late pregnancy to early lactation J. Dairy Sci. 98(11),7757-7770(2015).
3. Praggastis, M., Tortelli, B., Zhang, J., et al. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele J. Neurosci. 35(21),8091-8106(2015).

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide Preparation Products And Raw materials

Raw materials

Preparation Products

N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide Suppliers

Global Suppliers ( 24)
Supplier Tel Email Country ProdList Advantage
Shanghai Aladdin Bio-Chem Technology Co.,LTD 400-6206333 13167063860 anhua.mao@aladdin-e.com China 29977 65
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9799 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Chengdu Huachun Technology Co., Ltd 400-1166-196 15982826727 cdhxsj@163.com China 14571 60
Shanghai Zhen Li Biological Technology Co., Ltd 021-16621358918; 18516310516;16621358918;13045646768 zhenlipharma888@163.com China 19060 58
Shanghai Hongye Biotechnology Co. Ltd 400-9205774 400-920-5774 sales@glpbio.cn China 6705 58
BOC Sciences +1-631-485-4226 inquiry@bocsci.com United States 19935 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946 1461866103@qq.com China 16103 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11123 58
Shaanxi Dideu Medichem Co. Ltd +86-29-81139210 17389186172 1077@dideu.com China 3999 58
Supplier Advantage
Shanghai Aladdin Bio-Chem Technology Co.,LTD 65
Shanghai EFE Biological Technology Co., Ltd. 58
Shanghai YuanYe Biotechnology Co., Ltd. 60
Chengdu Huachun Technology Co., Ltd 60
Shanghai Zhen Li Biological Technology Co., Ltd 58
Shanghai Hongye Biotechnology Co. Ltd 58
BOC Sciences 58
Beijing xinyanhui pharmaceutical research and development co., LTD 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 58
Shaanxi Dideu Medichem Co. Ltd 58

View Latest Price from N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
C16 Lactosylceramide pictures 2026-08-07 C16 Lactosylceramide
4201-62-1
 $1.00-45.00 1KG 99% 420000KG Shaanxi Dideu Medichem Co. Ltd

4201-62-1 (N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide) Related Search:

Hexadecanamide D-lactosyl-1-1'-N-nervonoyl-D-erythro-sphingosine D-lactosyl--1,1' N-octanoyl-D-erythro-sphingosine C16 Globotriaosylceramide (d18:1/16:0) N-PALMITOYL-D-SPHINGOMYELIN
C16 Sphingomyelin-d9 (d18:1/16:0-d9)

1of2

(2S,3R,4E)-2-(Hexadecanoylamino)-1-(4-O-β-D-galactopyranosyl-β-D-glucopyranosyloxy)-4-octadecen-3-ol C16 Lactosylceramide (d18:1/16:0)) C16:0LacCer C16LacCer N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide N-Hexadecanoyl-1-O-(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)sphingosine N-Hexadecanoyl-lactosylceramide Ceramide β-D-lactosides C16 Lactosyl(ss) Ceramide(d18:1/16:0) Hexadecanamide, N-[(1S,2R,3E)-1-[[(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]- LacCer d18:1/16:0 (Galb1,4GlcbCeramide) LacCer(d18:1/16:0) D-lactosyl--1,1' N-palmitoyl-D-erythro-sphingosine C16 Lactosyl(β) Ceramide (d18:1/16:0) C16 Lactosylceramide D-lactosyl-β-1,1' N-palmitoyl-D-erythro-sphingosine 4201-62-1